Globus Medical's $3 bln deal for NuVasive to fortify spinal business spooks investors

in an all-stock deal valued at about $3 billion to build scale in the competitive market for spinal devices.

NuVasive shareholders will receive 0.75 of Globus shares, implying a per-share offer of $57.72 and a premium of about 26% to Wednesday's close. Shares of Globus Medical fell more than 17%, with analysts raising concerns around deals in spinal device space.Similar deals in the spinal device market, such as Stryker

acquiring K2M Group and several others, have had more revenue "dis-synergies and loss of integration" than other areas of medtech over the years, said Baird analyst Jeffrey Johnson."To double-down on spine is somewhat surprising in our view and adds a lower growth organization," said BTIG analyst Ryan Zimmerman.

I touch I was getting two billion but I'll take my three billion failed diplomatic experiment safety and Liberty 🗽💳✔️

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

NuVasive rallies while Globus Medical moves down after companies announce all-stock merger dealGlobus Medical said Thursday it will pay 0.75 a share of its stock for each share of NuVasive stock in a deal that values NuVasive at about $3.1 billion or...
Source: MarketWatch - 🏆 3. / 97 Read more »